Meny

Javascript verkar inte påslaget? - Vissa delar av Lunds universitets webbplats fungerar inte optimalt utan javascript, kontrollera din webbläsares inställningar.
Du är här

Prognostic and chemotherapy predictive value of gene-expression phenotypes in primary lung adenocarcinoma.

Författare:
  • Markus Ringnér
  • Göran B Jönsson
  • Johan Staaf
Publiceringsår: 2016
Språk: Engelska
Sidor: 218-229
Publikation/Tidskrift/Serie: Clinical Cancer Research
Volym: 22
Nummer: 1
Dokumenttyp: Artikel i tidskrift
Förlag: American Association for Cancer Research

Abstract english

Purpose Primary lung adenocarcinoma remains a deadly disease. Gene expression phenotypes (GEPs) in adenocarcinoma have potential to provide clinically relevant disease stratification for improved prognosis and treatment prediction, given appropriate clinical and methodological validation. Experimental Design 2395 transcriptional adenocarcinoma profiles were assembled from 17 public cohorts and classified by a nearest centroid GEP classifier into three subtypes: terminal respiratory unit (TRU), proximal-proliferative, and proximal-inflammatory, and additionally scored by five transcriptional metagenes representing different biological processes, including proliferation. Prognostic and chemotherapy predictive associations of the subtypes were analyzed by univariate and multivariate analysis using overall survival or distant metastasis-free survival as endpoints. Results Overall, GEPs were associated with patient outcome in both univariate and multivariate analyses, although not in all individual cohorts. The prognostically relevant division was between TRU and non-TRU classified cases, with expression of proliferation-associated genes as a key prognostic component. In contrast, GEP classification was not predictive of adjuvant chemotherapy response. GEP classification showed stability to random perturbations of genes or samples and alterations to classification procedures (typically <10% of cases per cohort switching subtype). High classification variability (>20% of cases switching subtype) was observed when removing larger or entire fractions of a single subtype, due to gene-centering shifts not addressable by the classifier. Conclusions In a large-scale evaluation we show that GEPs add prognostic value to standard clinicopathological variables in lung adenocarcinoma. Subject to classifier refinement and confirmation in prospective cohorts, GEPs have potential to impact the prognostication of adenocarcinoma patients through a molecularly driven disease stratification.

Keywords

  • Cancer and Oncology

Other

Published
  • Research Group Lung Cancer
  • ISSN: 1078-0432
Markus Ringnér
E-post: markus [dot] ringner [at] biol [dot] lu [dot] se

Forskningsingenjör

Molekylär cellbiologi

B-A317

Sölvegatan 35, Lund

4